Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes

J Clin Invest. 2001 Sep;108(6):871-8. doi: 10.1172/JCI13296.

Abstract

The lineage relationship between short-lived effector T cells and long-lived memory cells is not fully understood. We have described T-GFP mice previously, in which naive and early activated T cells express GFP uniformly, whereas cells that have differentiated into effector cytotoxic T cells selectively lose GFP expression. Here we studied antigen-specific CD8 T cell differentiation using T-GFP mice crossed to the TCR transgenic (Tg) mice P14 (specific for the lymphocytic choriomeningitis virus glycoprotein peptide, gp33-41). After activation with antigenic peptide, P14XT-GFP CD8(+) T cells cultured in high-dose IL-2 developed into cells with effector phenotype and function: they were blastoid, lost GFP expression, expressed high levels of activation and effector markers, and were capable of immediate cytotoxic function. In contrast, cells cultured in IL-15 or low-dose IL-2 never developed into full-fledged effector cells. Rather, they resembled memory cells: they were smaller, were GFP(+), did not express effector markers, and were incapable of immediate cytotoxicity. However, they mediated rapid-recall responses in vitro. After adoptive transfer, they survived in vivo for at least 10 weeks and mounted a secondary immune response after antigen rechallenge that was as potent as endogenously generated memory cells. In addition to providing a simple means to generate memory cells in virtually unlimited numbers, our results suggest that effector differentiation is not a prerequisite for memory cell generation.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antigens, Viral / immunology
  • Cell Differentiation
  • Cell Division / drug effects
  • Glycoproteins / immunology
  • Green Fluorescent Proteins
  • Immunologic Memory*
  • In Vitro Techniques
  • Interleukin-15 / pharmacology
  • Interleukin-2 / pharmacology
  • Luminescent Proteins / genetics
  • Lymphocyte Activation
  • Mice
  • Mice, Transgenic
  • Peptide Fragments / immunology
  • Receptors, Antigen, T-Cell / genetics
  • T-Lymphocytes, Cytotoxic / cytology*
  • T-Lymphocytes, Cytotoxic / drug effects
  • T-Lymphocytes, Cytotoxic / immunology*
  • Viral Proteins / immunology

Substances

  • Antigens, Viral
  • Glycoproteins
  • Interleukin-15
  • Interleukin-2
  • Luminescent Proteins
  • Peptide Fragments
  • Receptors, Antigen, T-Cell
  • Viral Proteins
  • glycoprotein peptide 33-41, Lymphocytic choriomeningitis virus
  • Green Fluorescent Proteins